SIRT6 and colorectal carcinoma: When evaluated in CRC cell lines, a type of tumor characterized by heavy downregulation of SIRT6, MDL-811 caused a dose-dependent decrease of H3K9Ac, H3K18Ac, and H3K56Ac levels and antiproliferative effects associated with marked G0/G1 cell cycle arrest.